CPIX
$3.56
Cumberland Pharmaceu
$.02
.56%
CPIX
Earnings Whisper ®
N/A
1st Quarter March 2020
Consensus:  $0.00
Revenue:  $9.64 Mil
Wednesday
Jun 17
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CPIX reports earnings?
Beat
Meet
Miss

Where is CPIX's stock price going from here?
Up
Flat
Down
Stock chart of CPIX
Analysts
Summary of analysts' recommendations for CPIX
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.